The Article by Nan Yu and colleagues[@bib1] provides timely information to inform policies concerning essential pregnant workers. In past epidemics (eg, H1N1 influenza, Middle East respiratory syndrome, and severe acute respiratory syndrome), pregnant women and their offspring have been at increased risk of morbidity and mortality.[@bib2] By contrast, the maternal, fetal, and neonatal outcomes reported by Yu and colleagues were surprisingly good. When considering this study, it is important to note that all of the women were full-term (≥37 weeks) and underwent caesarean section within 3 days of presentation. Prompt delivery allowed for experimental treatment in all women; all patients received antiviral treatment, including ganciclovir, oseltamivir, interferon, and Arbidol (ie, umifenovir) tablets. Traditional Chinese medicine, such as Jinye Baidu granules or Lianhuaqingwen capsules, or both, was also administered to four of seven women, and five of seven received the steroid methylprednisolone. Because the safety of these interventions during pregnancy is not established, infection in the first, second, or early third trimester, without immediate delivery, might not lead to similar favourable outcomes. For example, in a case series on nine pregnant women with a larger range of gestational ages and severe cardiopulmonary disease attributed to COVID-19, seven of nine died.[@bib3] Although the worse outcomes of this non-systematic series do not establish risk, they do highlight that low risk should not be assumed in the absence of multicentre databases to study pregnancy-related outcomes.

Furthermore, although only one newborn baby was found to have severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the study by Yu and colleagues, only three of the seven babies were tested, and the possibility of vertical transmission has since been raised in larger studies.[@bib4] Finally, SARS-CoV-2 infection induces a hypercoagulable state, including elevated levels of D-dimer and fibrinogen, and sometimes progresses to disseminated intravascular coagulation;[@bib5] this complication could be especially dangerous in pregnancy, given a normal underlying hypercoagulable state. The case series by Yu and colleagues provides a starting point for epidemiological studies, but the medical community needs to be circumspect in their conclusions and protect vulnerable workers until safety can be established for both mother and baby.
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